PRESS RELEASE published on 06/10/2024 at 14:00, 2 years 5 months ago Galimedix Therapeutics establishes Scientific Advisory Board of renowned retina experts as company prepares to enter Phase 2 clinical study with GAL-101 Galimedix Therapeutics forms Scientific Advisory Board of retina experts to guide Phase 2 study with GAL-101 eye drops for dry AMD, addressing unmet medical need Scientific Advisory Board Galimedix Therapeutics Phase 2 Study Dry AMD Retina Experts
BRIEF published on 03/08/2024 at 10:05, 2 years 8 months ago Galimedix Therapeutics dévoile des données prometteuses sur le traitement de la maladie d'Alzheimer à l'occasion de l'AD/PD™ 2024 Développement Clinique GAL-201 La Maladie D'Alzheimer Effets Neuroprotecteurs Fonction Cognitive
BRIEF published on 03/08/2024 at 10:05, 2 years 8 months ago Galimedix Therapeutics Unveils Promising Data on Alzheimer’s Treatment at AD/PD™ 2024 Clinical Development GAL-201 Alzheimer’s Disease Neuroprotective Effects Cognitive Function
PRESS RELEASE published on 03/08/2024 at 10:00, 2 years 8 months ago Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024 Galimedix Therapeutics presents new scientific data at AD/PD(TM) 2024, showing neuroprotective effects of GAL-201 for Alzheimer’s disease treatment, targeting misfolded Aβ monomers to prevent toxic aggregation Alzheimer's Disease Galimedix Therapeutics Neuroprotective Effects Scientific Data AD/PD 2024
BRIEF published on 02/28/2024 at 14:00, 2 years 8 months ago Galimedix Therapeutics présente de nouvelles données précliniques sur le GAL-201 lors de la conférence AD/PD™ 2024 GAL-201 Maladie D'Alzheimer Préclinique AD/PD™ 2024 Galimedix Therapeutics
BRIEF published on 02/28/2024 at 14:00, 2 years 8 months ago Galimedix Therapeutics Presents New Preclinical Data on GAL-201 at AD/PD™ 2024 Conference Alzheimer's Disease GAL-201 AD/PD™ 2024 Galimedix Therapeutics Preclinical
PRESS RELEASE published on 02/28/2024 at 14:00, 2 years 8 months ago Galimedix Therapeutics announces new pre-clinical data with GAL-201 in an Alzheimer's disease transgenic model to be presented at AD/PD™ 2024 Conference Galimedix Therapeutics to present new pre-clinical data with GAL-201 in an Alzheimer's disease transgenic model at AD/PD™ 2024 Conference, showing promise in targeting amyloid beta oligomers and protofibrils Alzheimer's Disease GAL-201 Galimedix Therapeutics Pre-clinical Data AD/PD™ 2024 Conference
PRESS RELEASE published on 10/25/2023 at 14:00, 3 years ago Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations
Published on 11/19/2026 at 11:00, 55 minutes ago American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
Published on 11/19/2026 at 10:00, 1 hour 55 minutes ago Temas Signs RCL Validation Services Contract with Québec Mineral Company Near La Blache and Proposed Baie-Comeau Demonstration Plant Site; Appoints Anthony Travers to Board
Published on 11/19/2026 at 04:25, 7 hours 30 minutes ago Predictiv AI Announces Appointment of Interim Chief Executive Officer
Published on 11/18/2026 at 23:30, 12 hours 25 minutes ago Jericho Energy Ventures Provides Update on Oil and Gas Joint Venture Credit Facility
Published on 11/18/2026 at 23:30, 12 hours 25 minutes ago Presentation to Swiss Mining Institute Conference
Published on 11/19/2026 at 11:40, 14 minutes ago Xinhua Silk Road: E China's Jiangxi eyes deeper cooperation with German companies for growth together
Published on 11/19/2026 at 11:15, 40 minutes ago LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong
Published on 11/19/2026 at 11:09, 45 minutes ago PNE Group receives permits for three wind energy projects with 72 MW in Germany
Published on 11/19/2026 at 08:30, 3 hours 25 minutes ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 08:30, 3 hours 25 minutes ago Souveraineté des données : Cegedim ouvre EB6, un datacenter nouvelle génération pour l'IA et la haute densité
Published on 11/19/2026 at 08:00, 3 hours 55 minutes ago EXOR VA RENFORCER SA PARTICIPATION DANS BIOMÉRIEUX
Published on 11/19/2026 at 07:30, 4 hours 25 minutes ago Gimv investeert in SpiraTec, specialist in automatisering en digitale transformatie in de procesindustrie